Skip to content
DataLookout
Menu

NCT07894302

Improving Women's Fertility Awareness and Reducing Anxiety Through Ovarian Reserve Screening and AI Counseling

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Change in Fertility Intentions and Reproductive Planning
Timeframe: 2 to 4 weeks post-intervention

Arms and interventions

Intervention: AMH Testing with AI-Enabled CounselingExperimental

Participants undergo Anti-Müllerian Hormone (AMH) blood testing. Personalized biomarker results and tailored fertility counseling are delivered via the interactive AI conversational agent ("Shelby"). Outcomes are assessed post-intervention.

Intervention: AMH Testing with Static Lab ReportExperimental

Participants undergo Anti-Müllerian Hormone (AMH) blood testing. Biomarker results are delivered via a conventional static laboratory report displaying reference ranges without AI interaction.

Control: Non-AMH with AI-Driven Fertility EducationActive comparator

Participants do not undergo AMH blood testing. If requested, participants are provided digital access to the AI conversational agent ("Shelby") for general fertility and reproductive health education without personalized biomarker data.

Control: Non-AMH with Standard Educational WebsiteActive comparator

Participants do not undergo AMH blood testing and serve as the standard control. If requested, participants are provided access to standard informational websites/materials regarding general reproductive health.

Behavioral: AI-Enabled Fertility Counseling, Standard Educational Materials or PDF laboratory reports

Sites

1 site in 1 country

  • City University of Hong KongHong Kong, Kowloon, Hong Kong